Skip to Content

VIDEO: Open Orphan’s Maurice Treacy details pharma services firm’s ambitious growth plans in exclusive ValueTheMarkets presentation (ORPH)

On Wednesday, ValueTheMarkets’ Ben Turney hosted Maurice Treacy, director at rare disease and orphan drug-focused pharma services company Open Orphan, in a recorded presentation and interview.

Treacy began by providing shareholders and potential investors with a detailed run through his firm’s robust range of services including its Virtual Rep database and its Genomic Health Data platform. He then went on to cover the opportunity on offer in Europe’s fast-growing orphan drug market and Open Orphan’s plans to consolidated the region’s fragmented pharma services sector through acquisitions.

Following an initial presentation, Treacy took a number of audience questions. These spanned a number of interesting topics such as the background of Open Orphan’s board, the company’s competition, its growth strategy, and the potential for a re-rate in its valuation.

For a full recording of the presentation, please see below:

Valuethemarkets.com and Dynamic Investor Relations Ltd are not responsible for the content or accuracy of this article.  News and research are not recommendations to deal, and investments may fall in value so that you could lose some or all of your investment. Past performance is not an indicator of future performance.

  • Daniel Flynn does not hold any position in the stock(s) and/or financial instrument(s) mentioned in the piece.
  • Daniel Flynn has been paid to produce this piece by the company or companies mentioned above.
  • Ben Turney does not hold any position in the stock(s) and/or financial instrument(s) mentioned in the piece.
  • Ben Turney has been paid to produce this piece by the company or companies mentioned above.
  • Dynamic Investor Relations Ltd, the owner of ValueTheMarkets.com, has been paid for the production this piece by the company or companies mentioned above.

Related Articles

Headlines

teathers app screenshot

App Empowering Private Investors

Crowd Equity for Placings, IPOs and Live Market Blockbuilds, designed to give provate investors access to placements and Intial Public Offerings (IPOs), predominantly on the London Stock Exchange’s Alternative Investment Market (AIM).